Description
Updated survival data on maintenance therapy with olaparib in patients with platinum-sensitive recurrent ovarian cancer
Article: Updated survival data on maintenance therapy with olaparib in patients with platinum-sensitive recurrent ovarian cancer
€2.42
Related products
-
Article: Highlights in melanoma
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart -
Article: Highlights in gynaecological cancers
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
